Psychstocks recently announced Revive Therapeutics (CSE: RVV) as its latest featured Psychedelic Pick at $0.245 per share. Today, RVV gained by 29.51% to close at its high of day of $0.395 per share and is now up by 61.22% from our initial profile price.
Past performance is not an indicator of future returns. Psychstocks is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. The parent company of Psychstocks has been compensated by RVV USD$30,000 cash for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.